Jas Kalsi is a Consultant Urological surgeon with a special interest in Andrology and Renal tract stone disease.
Professional profile
Jas trained in Medicine at UCL Medical School in London and then underwent general surgical training at Kings and Royal Free.
Following a period of research into smooth muscle physiology at the Wolfson Institute, UCL, he trained in Urology on the Imperial Higher Urological training programme, and subsequently undertook a fellowship in andrological / genito-urethral surgery at the Institute of Urology, UCL.
He has published and presented extensively in the field of andrology, and previously won the prestigious International Society for Sexual Medicine Young Investigator Award.
Clinical Interests
Jas has a passion for treating patients using minimally invasive techniques so that they may return to normal activities quickly.
He is a specialist in the management of men with both erectile and fertility problems using the latest techniques including micro-surgery. He is able to offer a full spectrum of options so that the care of the patient may be individualised.
He also commonly deals with patients with Peyronie's disease.
Jas also offers a state of the art renal tract stone service which includes the use of holmium laser and flexible digital ureteroscopes to allow excellent vision and stone removal with minimal trauma.
- General Urology
- Andrology (Male infertility and erectile problems)
- Stone Disease (Minimally invasive surgery)
- Green light and Holmium laser prostatectomy
NHS Hospitals
Wexham Park Hospital Slough, Berkshire
Heatherwood Hospital, Ascot, Berkshire
King Edward VII Hospital, Windsor, Berkshire
Bracknell Out-Patients Centre, Bracknell, Berkshire
Private Hospitals The Princess Margaret Hospital, Windsor, Berkshire
Spire Thames Valley, Wexham, Slough, Berkshire
The Clementine Chchill, Harrow Middlesex
CredentialsBSc Pharmacology with Immunology First Class Honors (University College London 1993)
MBBS with Honors (UCL Medical School 1991-1997)
King
Research - Institute of Urology and Wolfson Institute for Biomedical Research, UCL (2001-2003) (Molecular biology of urogenital smooth muscle).
Imperial Urological Training Programme, London North (2004-2009)
FRCS (Urol.) 2008
Fellowship in Andrological Surgery, UCLH, London (2009-2010)
MembershipsRoyal College of Surgeons of Edinburgh and England
British Association of Urological Surgeons
European Urology Association
Urology Section of the Royal Society of Medicine
British and European Societies of Sexual Medicine
PublicationsIn the era of micro-dissection sperm retrieval is an isolated testicular biopsy necessary in the management of men with non-obstructive azoospermia?
JS Kalsi, M-Y Thum, H Abdullah, S Minhas
BJUi 2011
Analysis of the outcome of intracytoplasmic sperm injection using fresh or frozen sperm.
JS Kalsi, M-Y Thum, A Muneer, J Pryor, H Abdullah, S Minhas.
BJU Int. 2011 Apr;107(7):1124-8.
Glans Resurfacing for the Treatment of Carcinoma In Situ of the Penis: Surgical Technique and Outcomes.
M Shabbir, A Muneer,
JS Kalsi, CJ Shukla,E Zacharakis, G Garaffa, D Ralph, S Minhas.
Eur Urol. 2010 Oct 20
Plaque Incision and Fascia Lata Grafting in the Surgical Management of Peyronie
JS Kalsi, N Christopher, DJ Ralph, S Minhas.
BJU Int 2006 Jul;98(1):1105
The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease.
JS Kalsi, N Christopher, S Minhas, DJ Ralph.
BJU Int. 2005 May;95(7):1029-33
Plaque incision and grafting as salvage after a failed Nesbit procedure for Peyronie's disease.
A Muneer,
JS Kalsi, S Minhas, DJ Ralph.
BJU Int. 2004;94(6):878-80.
The management of low-flow priapism with the immediate insertion of a penile prosthesis.
RW Rees,
J Kalsi, S Minhas, J Peters, P Kell, DJ Ralph
BJU Int. 2002;90(9):893-7
A nitric oxide-releasing PDE5 inhibitor relaxes human corpus cavernosum in the absence of endogenous nitric oxide
JS Kalsi, DJ Ralph, P Thomas, J Bellringer, PD Kell, S Cellek.
J Sex Med 2005; 2: 53
NCX-911, a Novel Nitric Oxide-Releasing PDE5 Inhibitor Relaxes Rabbit Corpus Cavernosum in the Absence of Endogenous Nitric Oxide.
JS Kalsi, PD Kell, DJ Ralph, S Cellek.
Int J Impot Res. 2004;16(2):195-200
A comparative study of sildenafil, NCX-911 and BAY41-2272 on the anococcygeus muscle of diabetic rats.
JS Kalsi, DJ Ralph, PD Kell, S Cellek.
Int J Impot Res. 2004;16(6):479-85
Bay 41-2272, A novel nitric oxide-independent soluble guanylyl cyclase activator, relaxes human and rabbit corpus cavernosum in vitro.
JS Kalsi, RW Rees, AJ Hobbs, M Royle, PD Kell, DJ Ralph, S Moncada, S Cellek.
J Urol 2003; 169(2):761-766
Cutaneous myasis of Cordylobia arthropophaga.
W Pepper, S Benagaram,
JS Kalsi, O Karim
Urology 2008 Jul; 72(1):65
A Pilonidal sinus presenting with erectile dysfunction.
JS Kalsi, S Minhas, M Arya, A Freeman, DJ Ralph.
Scand J Urol Nephrol. 2004;38(1):92-3
Massive bilateral angiomyolipomas resulting in respiratory failure.
JS Kalsi, S Minhas, M Arya, JL Peters, SN Venn, CRJ Woodhouse.
BJU Int 2002;90(9):968-9
Identical twins with dysplastic kidneys and ectopic left ureters.
JS Kalsi, M Arya, P Menezes, P Cuckow.
BJU Int200290(4cr),472
Grease gun injury to the penis.
JS Kalsi, M Arya, J. Peters, S Minhas, DJ Ralph.
J R Soc Med. 2002;95(5):254
Current oral treatments for male erectile dysfunction.
JS Kalsi; S Cellek; A Muneer; PD Kell; DJ Ralph; S Minhas. Expert Opinion on Pharmacotherapy; 3(11); 2002:1613-1629
Current concepts in the pharmacotherapy of benign prostatic hyperplasia
.
J Khastgir, M Arya, I Shergill, JS Kalsi, S Minhas, AR Mundy.Expert Opinion on Pharmacotherapy; 3(12) 2002:1727-1737
Priapism: a medical emergency.
JS Kalsi, M Arya, S Minhas, DJ Ralph.
Hosp Med. 2002;63(4):224-5
A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction.
S
Cellek, RW Rees JS Kalsi. Expert Opinion on Investigational Drugs. 11(11);2002:1563-1573
Early Peyronie
JS Kalsi, S Minhas, DJ Ralph.
CML-Urology 2002; 8(3):57-60
Erectile dysfunction: New treatments. Postgraduate Doctor.
JS Kalsi, S Minhas, PD Kell, DJ Ralph.
Postgraduate doctor, 2003
Hospital-acquired urinary tract infection.
JS Kalsi, M Arya, P Wilson, AR Mundy.
Int J Clin Pract. 2003;57(5):388-91
Oral agents for erectile dysfunction.
JS Kalsi, S Minhas, PD Kell, DJ Ralph.
Hosp Med. 2003;64(5):292-5.
Update on oral treatments for male erectile dysfunction.
JS Kalsi, PD Kell.
J Eur Acad Dermatol Venereol. 2004;18(3):267-74.
Cialis; A novel oral phosphodiesterase inhibitor for the treatment for male erectile dysfunction.
S Minhas,
JS Kalsi, DJ Ralph.
Hosp Med. 2003;64(10):589-92.
Novel PDE5 inhibitors in the management of erectile dysfunction.
JS Kalsi, A Muneer, PD Kell, DJ Ralph, S Minhas.
Reprod Biomed Online. 2003 Oct-Nov;7(4):456-61.
The management of Peyronie
A Muneer,
JS Kalsi, S Minhas, DJ Ralph.
Accepted by Repro BioMed
Electromotive drug administration with Mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma
J Kalsi, SJ Harland, MR Feneley
Expert opinion in Investigational Drug Delivery 2008 Jan;5(1):137-45